National
Cardiovascular
Partners

National Cardiovascular Partners (NCP), a division of Fresenius Medical Care North America (FMCNA), is the market leader of the outpatient, hybrid cardiovascular center (ASC/office-based lab) model. Partnering with physician entrepreneurs, NCP oversees the development, management, and operations of the centers, allowing physicians to focus on providing exceptional and innovative patient care.

We are pleased to announce that Medicare patients are now approved to receive certain cardiac treatments in the outpatient setting in addition to diagnostics. By allowing for diagnosis and treatment in one location, patients will no longer have to travel to multiple appointments. The newly approved treatments under Medicare relate to three specific percutaneous coronary intervention (PCI) procedures, including drug eluding stent placement.

To learn more, please read the official fact sheet from the Centers for Medicare and Medicaid Services website.